Epiphany

About:

Epiphany Biosciences develops therapeutic products and diagnostic technologies that can prevent or cure the spread of pathogenic viruses.

Website: http://www.epiphanybio.com

Top Investors: Visa, Wexford Capital, CDIB BioScience Ventures

Description:

Epiphany Biosciences is developing both therapeutic products and diagnostic technologies that treat or prevent the spread of pathogenic viruses. Epiphany Biosciences is a privately-held company located in San Francisco, CA. To support its mission, Epiphany has assembled a world-class team of virologists, clinicians, and drug development experts with extensive pharmaceutical business experience to lead the company forward.

Total Funding Amount:

$36M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

San Francisco, California, United States

Founded Date:

1998-01-01

Contact Email:

info(AT)epiphanybio.com

Founders:

Fred Volinsky

Number of Employees:

11-50

Last Funding Date:

2007-03-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai